By expenditures
| Name | Title | Type |
|---|---|---|
| Byron Schueneman | Chief Financial Officer | Auditee |
| Christopher McKellar | Partner | Auditee |
| Karen Rodgers | Senior Auditor | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 358495 | 2024 | 2025-06-10 | Georgia Department of Audits and Accounts | $268.98M |
| 354728 | 2023 | 2025-04-28 | Mauldin & Jenkins LLC | $210.00M |
| 50245 | 2022 | 2023-07-05 | Georgia Department of Audits and Accounts | $324.04M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 358495 | 2024 | 2025-06-10 | 1140775 | 2024-001 | Significant Deficiency | - | B |
| 358495 | 2024 | 2025-06-10 | 1140774 | 2024-001 | Significant Deficiency | - | B |
| 358495 | 2024 | 2025-06-10 | 1140773 | 2024-001 | Significant Deficiency | - | B |
| 358495 | 2024 | 2025-06-10 | 564333 | 2024-001 | Significant Deficiency | - | B |
| 358495 | 2024 | 2025-06-10 | 564332 | 2024-001 | Significant Deficiency | - | B |
| 358495 | 2024 | 2025-06-10 | 564331 | 2024-001 | Significant Deficiency | - | B |
| 354728 | 2023 | 2025-04-28 | 1132454 | 2023-005 | Material Weakness | - | F |
| 354728 | 2023 | 2025-04-28 | 1132453 | 2023-004 | Material Weakness | - | A |
| 354728 | 2023 | 2025-04-28 | 1132452 | 2023-004 | Material Weakness | - | A |
| 354728 | 2023 | 2025-04-28 | 1132451 | 2023-004 | Material Weakness | - | A |
| 354728 | 2023 | 2025-04-28 | 556012 | 2023-005 | Material Weakness | - | F |
| 354728 | 2023 | 2025-04-28 | 556011 | 2023-004 | Material Weakness | - | A |
| 354728 | 2023 | 2025-04-28 | 556010 | 2023-004 | Material Weakness | - | A |
| 354728 | 2023 | 2025-04-28 | 556009 | 2023-004 | Material Weakness | - | A |
| 50245 | 2022 | 2023-07-05 | 626980 | 2022-003 | Significant Deficiency | - | F |
| 50245 | 2022 | 2023-07-05 | 626979 | 2022-002 | Significant Deficiency | - | AB |
| 50245 | 2022 | 2023-07-05 | 626978 | 2022-003 | Significant Deficiency | - | F |
| 50245 | 2022 | 2023-07-05 | 623228 | 2022-002 | Significant Deficiency | - | AB |
| 50245 | 2022 | 2023-07-05 | 623227 | 2022-001 | Significant Deficiency | - | AB |
| 50245 | 2022 | 2023-07-05 | 623226 | 2022-003 | Significant Deficiency | - | F |
| 50245 | 2022 | 2023-07-05 | 623225 | 2022-002 | Significant Deficiency | - | AB |
| 50245 | 2022 | 2023-07-05 | 623224 | 2022-001 | Significant Deficiency | - | AB |
| 50245 | 2022 | 2023-07-05 | 50538 | 2022-003 | Significant Deficiency | - | F |
| 50245 | 2022 | 2023-07-05 | 50537 | 2022-002 | Significant Deficiency | - | AB |
| 50245 | 2022 | 2023-07-05 | 50536 | 2022-003 | Significant Deficiency | - | F |
| 50245 | 2022 | 2023-07-05 | 46786 | 2022-002 | Significant Deficiency | - | AB |
| 50245 | 2022 | 2023-07-05 | 46785 | 2022-001 | Significant Deficiency | - | AB |
| 50245 | 2022 | 2023-07-05 | 46784 | 2022-003 | Significant Deficiency | - | F |
| 50245 | 2022 | 2023-07-05 | 46783 | 2022-002 | Significant Deficiency | - | AB |
| 50245 | 2022 | 2023-07-05 | 46782 | 2022-001 | Significant Deficiency | - | AB |